[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4861 Introduced in House (IH)]

<DOC>






114th CONGRESS
  2d Session
                                H. R. 4861

 To amend the Public Health Service Act to authorize grants to health 
 centers to expand access to evidence-based substance abuse treatment 
                               services.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 23, 2016

 Ms. DeLauro introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend the Public Health Service Act to authorize grants to health 
 centers to expand access to evidence-based substance abuse treatment 
                               services.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Access to Substance Abuse Treatment 
Act of 2016''.

SEC. 2. EXPANDED ACCESS TO SUBSTANCE ABUSE TREATMENT SERVICES.

    Title V of the Public Health Service Act is amended--
            (1) by redesignating the second section 514 (42 U.S.C. 
        290bb-9; relating methamphetamine and amphetamine treatment 
        initiative) as section 514B; and
            (2) by inserting after section 514B, as so redesignated, 
        the following:

``SEC. 514C. EXPANDED ACCESS TO SUBSTANCE ABUSE TREATMENT SERVICES.

    ``(a) In General.--The Director of the Center for Substance Abuse 
Treatment shall make grants to Federally qualified health centers, 
substance abuse treatment centers, rehabilitation treatment centers, or 
residential treatment centers to expand access to substance abuse 
treatment services for adults, adolescents, and children by--
            ``(1) increasing education, screening, care coordination, 
        risk reduction interventions, or counseling regarding the 
        availability of testing, treatment, and clinical management for 
        patients with or at risk of HIV/AIDS, hepatitis C, and other 
        diseases associated with opioid use disorders;
            ``(2) enhancing clinical workflow to improve substance 
        abuse treatment services;
            ``(3) enhancing the use of health information technologies 
        to improve the effectiveness of substance abuse treatment 
        services and increase patient engagement;
            ``(4) educating patients and community members on opioid 
        use disorders, including the use of opioid antagonists in 
        preventing opioid overdose;
            ``(5) expanding treatment capacity in rural and underserved 
        communities through the use of telemedicine;
            ``(6) providing treatment transition and coverage for 
        patients reentering communities from criminal justice settings 
        or other rehabilitative settings;
            ``(7) training and certifying opioid use disorder treatment 
        providers, including physicians, nurses, counselors, social 
        workers, care coordinators, and case managers;
            ``(8) supporting innovative delivery of medication-assisted 
        treatment; and
            ``(9) enhancing prevention using evidence-based methods 
        proven to reduce the number of persons with opioid use 
        disorders.
    ``(b) Priority.--In awarding grants under this subsection, the 
Director shall prioritize grants to Federally qualified health centers, 
substance abuse treatment centers and programs, rehabilitation 
treatment centers and programs, and residential treatment centers--
            ``(1) serving communities with a greater incidence of 
        substance abuse; or
            ``(2) providing, or proposing to incorporate, medication-
        assisted treatment.
    ``(c) Requirements.--
            ``(1) Evidence-based, cost-effective.--Services funded 
        through a grant under this subsection shall be--
                    ``(A) evidence-based; and
                    ``(B) cost-effective.
            ``(2) Manner of providing services.--Services funded 
        through a grant under this section--
                    ``(A) may be provided by the grantee directly or 
                through referrals to other providers with which the 
                grantee has a formal relationship; and
                    ``(B) shall be provided in a manner reflecting 
                person-centered care.
    ``(d) Providers.--Providers treating patients for substance use 
disorders pursuant to a grant under this subsection shall be licensed 
or credentialed, as applicable, in the States involved to treat such 
patients for such disorders.
    ``(e) Definitions.--In this section:
            ``(1) The term `Federally qualified health center' has the 
        meanings given the terms in section 1861(aa) of the Social 
        Security Act.
            ``(2) The term `substance abuse treatment services' 
        includes the following:
                    ``(A) Screening, assessment, and diagnosis, 
                including risk assessment.
                    ``(B) Patient-centered treatment planning or 
                similar processes, including risk assessment and crisis 
                planning.
                    ``(C) Outpatient substance use services, including 
                medication-assisted treatment, and related behavioral 
                health services.
                    ``(D) Targeted case management.
                    ``(E) Peer support, counselor services, and family 
                supports.
                    ``(F) Harm reduction and syringe services programs.
    ``(f) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this subsection $1,000,000,000 for each of 
fiscal years 2017 through 2022.''.
                                 <all>